Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Institut Bergonié
Intensity Therapeutics, Inc.
Ipsen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hutchmed
University of Virginia
Hoffmann-La Roche
City of Hope Medical Center
Ludwig Institute for Cancer Research
Novartis
University of South Florida
Amgen
M.D. Anderson Cancer Center
The University of Texas Health Science Center, Houston
Columbia University
University of South Florida
Dana-Farber Cancer Institute
INSYS Therapeutics Inc